InsiderClue
Insiders · Profile

Shukla Sanjay

President and CEO at aTYR PHARMA. Filing since 7 Feb 2020. CIK 0001671026

Company
Date
Role
Action
Shares
Amount
Of holding
ATYR aTYR PHARMA INC
4 Feb 2026
President and CEO
Sold at will
3,745
$3.66K
2.4%
ATYR aTYR PHARMA INC
31 May 2024
President and CEO
Bought
20,000
$36.14K
17.2%
ATYR aTYR PHARMA INC
12 Dec 2023
President and CEO
Bought
12,000
$14.14K
12.7%
ATYR aTYR PHARMA INC
11 Dec 2023
President and CEO
Bought
3,000
$3.51K
3.3%
ATYR aTYR PHARMA INC
13 Nov 2023
President and CEO
Bought
13,578
$15.09K
17.5%
ATYR aTYR PHARMA INC
10 Nov 2023
President and CEO
Bought
1,422
$1.62K
1.9%
ATYR aTYR PHARMA INC
28 Jul 2023
President and CEO
Bought
15,000
$30.22K
24.5%
ATYR aTYR PHARMA INC
21 Nov 2022
President and CEO
Bought
10,000
$21.41K
24.5%
ATYR aTYR PHARMA INC
1 Jul 2022
President and CEO
Bought
15,000
$43.16K
58.1%
ATYR aTYR PHARMA INC
7 Jan 2022
President and CEO
Bought
5,000
$33.81K
24.0%
ATYR aTYR PHARMA INC
15 Nov 2021
President and CEO
Bought
2,500
$21.44K
13.7%
ATYR aTYR PHARMA INC
18 May 2021
President and CEO
Bought
10,000
$40.10K
121%
ATYR aTYR PHARMA INC
9 Feb 2021
President and CEO
Sold, plan not stated
778
$5.96K
8.6%
ATYR aTYR PHARMA INC
19 Jun 2020
President and CEO
Bought
6,000
$25.62K
465%
ATYR aTYR PHARMA INC
7 Feb 2020
President and CEO
Sold, plan not stated
745
$3.00K
36.6%
15 decisions on file.